Skip to main content

Table 2 Selected up-regulated genes identified in HNSCC*

From: Identification of potential therapeutic targets in human head & neck squamous cell carcinoma

GeneBank Access ID

Gene Symbol & Annotation

Log2 Fold Difference**

Immune Response

L19686

MIF, macrophage migration inhibitory factor

3.1

M13560

CD74, CD74 antigen

2.6

M63438

IGKC, immunoglobulin kappa constant

1.9

J03909

IFI30, interferon, gamma-inducible protein 30

1.5

AJ251549

IL26, interleukin 26

1.4

L33930

CD24, CD24 antigen

1.4

X16302

IGFBP2, insulin-like growth factor binding protein 2

1.4

S75725

IGFBP7, insulin-like growth factor binding protein 7

1.4

Cell Growth, Maintenance/Cell cycle Regulation

Y00503

KRT19, keratin 19

3.9

U43901

LAMR1, laminin receptor 1

3.2

AL031670

FTL, ferritin, light polypeptide

2.5

J00124

KRT14, keratin 14

2.5

X07696

KRT 15, keratin 15

2.4

X95404

CFL1, cofilin 1

2.3

D13627

CCT8, chaperonin subunit 8

2.1

AF026291

CCT4, chaperonin subunit 4

2.0

Z68228

JUP, junction plakoglobin

1.9

M26326

KRT18, keratin 18

1.8

L42583

KRT6C, keratin 6C

1.7

Translation and Protein Synthesis

AK001313

RPLP0, ribosomal protein LP0

4.1

L06499

RPL37A, ribosomal protein L37A

3.9

U73824

EIF4G2, translation initiation factor 4 gamma 2

3.2

M64241

RPL10, ribosomal protein L10

3.2

X69150

RPS18, ribosomal protein S18

3.1

M84711

RPS 3A, ribosomal protein S3A

3.0

NM_000996

RPL35A, ribosomal protein L35A

3.0

U25789

RPL21, ribosomal protein L21

2.9

L11566

RPL18, ribosomal protein L18

2.8

Z21507

EEF1D, eukaryotic translation elongation factor 1D

2.3

AL117412

EIF4A2, eukaryotic translation initiation factor 4A

2.2

AC002544

EIF3S8, eukaryotic translation initiation factor 3, subunit 8

2.1

Metabolism

Z23090

HSPB1, heat shock 27 kDa protein

4.2

M94856

FABP5, fat acid binding protein 5

3.7

NM_021130

PPIA, peptidylprolyl isomerase A (cyclophilin A)

2.9

M26252

PKM2, pyruvate kinase, muscle

2.6

NM_001679

ATP1B3, ATP synthase Na+/K+ transporting, beta 3

2.6

AF061735

ATP5H, ATP synthase H+ transporting subunit

2.1

Y00483

GPX1, glutathione peroxidase 1

2.0

AL021546

COX6A1, cytochrome c oxidase subunit VI a1

1.9

X13923

COX6B, cytochrome c oxidase subunit VI b

1.8

X13794

LDHB, lactate dehydrogenase B

1.7

Z85996

CDKN1A, cyclin-dependent kinase inhibitor 1A

1.7

M60483

PPP2CA, protein phosphatase 2 catalytic subunit

1.7

Y13936

PPM1G, protein phosphatase 1G

1.6

U09813

ATP5G3, ATP synthase H+ transporting subunit

1.6

D29011

PSMB5, proteasome subunit, beta 5

1.6

AF047181

NDUFB5, NADH dehydrogenase beta subcomplex 5

1.5

Ion Binding Proteins

Y07755

S100A2, S100 calcium binding protein A2

3.6

D38583

S100A11, S100 calcium binding protein A11

2.4

NM_020672

S100A14, S100 calcium binding protein A14

1.9

X99920

S100A13, S100 calcium binding protein A13

1.2

Others

M14328

ENO1, enolase 1

3.3

M26880

UBC, ubiquitin C

3.2

S54005

TMSB10, thymosin, beta 10

2.8

D87953

NDRG1, M-myc downstream regulated gene 1

2.4

M36981

NME2, non-metastatic cells 2 protein

2.3

AF055008

GRN, granulin

2.3

X57348

SFN, stratifin

2.3

U46751

SQSTM1, sequestosome 1

2.2

X67951

PRDX1, peroxiredoxin 1

2.1

X65607

MT1X, metallothionein 1X

1.5

X84709

FADD, Fas associated death domain

1.2

  1. * All selected genes with p-value < 0.01.
  2. **Log2 ratio fold-differences between tumors and normal tissues were determined by subtracting the ratio of genes in normal tissue versus uRNA from the ratio of genes in HNSCC tissues versus uRNA. (Log2 ratio of 1 equals to 2-fold difference between HNSCC and normal tissue; Log2 ratio of 2 equals to 4-fold difference between HNSCC and normal tissue, and so on)